Oh Boy – Masks and Dining – Again

Angie Szumlinski Health, Studies

Mask mandates were associated with statistically decreases in county-level daily COVID-19 case and death growth rates within 20 days of implementation. Allowing on-premises restaurant dining was associated with increases in county-level case and death growth rates within 41-80 days after reopening. State mask mandates and prohibiting on-premises dining at restaurants help limit potential exposure to SARS-CoV-2, reducing community transmission of …

COVID-19 Challenges – Administrator View

Angie Szumlinski Studies

Skilled nursing facilities (SNFs) have borne enormous burdens from COVID-19, accounting for 40% of COVID-19 deaths in the United States. SNFs have faced tremendous operational, clinical, and financial hurdles during the pandemic as well. Despite broad recognition of such problems, there is little systematic evidence about the experience of SNFs from the perspective of SNF leadership. In a study conducted …

COVID-19 and Heart Damage

Angie Szumlinski Health, Studies

Cardiac injury is a common condition among patients hospitalized with COVID-19, and it is associated with a higher risk of in-hospital mortality. To explore the association between cardiac injury and mortality in patients with COVID-19 a study was conducted from January 20, 2020 to February 10, 2020 in Wuhan China. The study concluded that although the exact mechanism of cardiac …

Airborne Pollen – COVID Risk

Angie Szumlinski Health, Studies

The outbreak of coronavirus pandemic appears to coincide with the tree pollen season in the northern hemisphere as it occurred in the spring of 2020. In a study conducted by an international team headed by researchers at the Technical University of Much (TUM) and the Helmholtz Zentrum München, it was determined that members of high-risk groups can protect themselves by …

Differentiate SARS-CoV-2, FLU A, FLU B and RSV

Angie Szumlinski Featured

Abbott Laboratories announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for the company’s Alinity™ m Resp-4-Plex molecular assay to detect and differentiate SARS-CoV-2, influenza A, influenza B and Respiratory Syncytial virus (RSV) in one test. This is an important tool because these viruses have similar symptoms but require different treatment approaches. This test …

Good News!

Angie Szumlinski Health

All major indicators of COVID-19 transmission in the United States continue to fall rapidly. Weekly new cases have fallen from 1.7 million at the national peak in early January to fewer than 600,000 the week of February 18, 2021, and cases have declined in every state. As we’ve seen at many points in the pandemic, case numbers are changing most …

Durability of SARS-CoV-2 Antibodies

Angie Szumlinski Studies

More than 500,000 residents in nursing homes and long-term care facilities have been infected in the United States, accounting for 40% of the total deaths from COVID-19. Among survivors, an understanding of the expected durability of the antibody response may be helpful in estimating the risk of a new infection. This is particularly important in preparation for another surge. Previous …

Variants – Challenges and Opportunities

Angie Szumlinski Announcements, News

SARS-CoV-2, like other RNA viruses, constantly changes through mutation, with new variants occurring over time. Generally, when new variants become more common, they do so because of some selective advantage to the virus. Among the numerous SARS-CoV-2 variants that have been detected, only a very small proportion are of public health concern because they are more transmissible, cause more severe …

Vaccine Safety

Angie Szumlinski Announcements, Health

After the administration of 13.8 million doses of Pfizer-BioNTech and Moderna COVID-19 vaccines to the U.S. population during the first month of the vaccination program, the post-authorization safety profiles for both vaccines are reassuring. Most (90.9%) VAERS reports were more non-serious events and involved local and systemic symptoms; transient local and systemic reactions were also frequently reported in v-safe. The …

Get Vaccinated!

Angie Szumlinski Health, Studies

After administration of 13.8 million doses of Pfizer-BioNTech and Moderna COVID-19 vaccines to the U.S. population during the first month of the vaccination program, the post-authorization safety profiles for both vaccines are reassuring. Most (90.9%) VAERS reports were for non-serious events and involved local and systemic symptoms; transient local and systemic reactions were also frequently reported in v-safe. Reports of …